Joëlle Micallef

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Topics

Intimate Partner Violence

Major Depressive Disorder

Postoperative Pain

Top Venues

Fundamental & clinical pharmacology

British journal of clinical pharmacology

Addiction (Abingdon, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs 38 (9) (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs (2024)
Pauline Gandolfo, Thomas Soeiro, Élisabeth Jouve, Bruno Revol, Amélie Daveluy, Célian Bertin, Céline Eiden, Valérie Gibaja, Leila Chaouachi, Marie-Christine Pérault-Pochat, Cécile Chevallier, Aurélie Aquizérate, Reynald Le Boisselier, Louise Carton, Maryse Lapeyre Mestre, Elisabeth Frauger, Clémence Lacroix, Joëlle Micallef
Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network. Fundamental & clinical pharmacology (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs 38 (9) (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs 38 (9) (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs 38 (9) (2024)
Clément Garnier, Martin Schein, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Gaétan Gentile, Maryse Lapeyre Mestre, Joëlle Micallef
Correction to: Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022. CNS drugs (2024)
Weniko Care, Sylvine Pinel, Laurène Dufayet, Jérôme Langrand, Joëlle Micallef, Dominique Vodovar
Trends in adverse drug reactions related to oral weak opioid analgesics in therapeutic use in adults: A 10-year French vigilances retrospective study. Fundamental & clinical pharmacology (2023)
Thomas Soeiro, Vincent Pradel, Maryse Lapeyre Mestre, Joëlle Micallef
Systematic assessment of non-medical use of prescription drugs using doctor-shopping indicators: A nationwide, repeated cross-sectional study. Addiction (Abingdon, England) (2023)
Amélie Daveluy, Michael Charles Bryan, Ghada Miremont-Salamé, Régis Lassalle, Clémentine Lacueille, Angela Grelaud, Marie Floccia, Françoise Haramburu, Maryse Lapeyre Mestre, Joëlle Micallef, Francesco Salvo
Analgesic switching in chronic users of dextropropoxyphene in France. Fundamental & clinical pharmacology (2023)
Sophie Roy, Robin Charreteur, Marianne Peries, Farid Kheloufi, Céline Eiden, Nicolas Nagot, Héléne Donnadieu, Joëlle Micallef, Hélène Peyrière
Abuse and misuse of second-generation antipsychotics: An analysis using VigiBase, the World Health Organisation pharmacovigilance database. British journal of clinical pharmacology 88 (10) (2022)
Anne Roussin, Thomas Soeiro, Charlotte Fouque, Emilie Jouanjus, Elisabeth Frauger, Nathalie Fouilhé, Michel Mallaret, Joëlle Micallef, Maryse Lapeyre Mestre, null null
Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data. British journal of clinical pharmacology 88 (8) (2022)
Thomas Soeiro, Joëlle Micallef
Commentary on Perry et al.: New means, new measures-without discarding all the previous ones! Addiction (Abingdon, England) 117 (1) (2021)
Jules Baudot, Thomas Soeiro, Marine Tambon, Nicolas Navarro, Gwenaëlle Veyrac, Salim Mezaache, Joëlle Micallef
Safety concerns on the abuse potential of esketamine: Multidimensional analysis of a new anti-depressive drug on the market. Fundamental & clinical pharmacology 36 (3) (2021)
Joelle Perri-Plandé, Ghada Miremont-Salamé, Joëlle Micallef, Cameron Herman, Marie Baumevieille, Frédéric Abriat, Maryse Lapeyre Mestre, Françoise Haramburu, Amélie Daveluy, null null
A 13-Year National Monitoring Study to Assess Narcotic Prescriptions and Indications (2007-2019). Drug safety (2021)
Robinson Gravier Dumonceau, Thomas Soeiro, Clémence Lacroix, Adeline Giocanti, Élisabeth Frauger, Salim Mezaache, Joëlle Micallef
Antidepressants abuse in subjects with opioid use disorders: A 10-year study in the French OPPIDUM program. Fundamental & clinical pharmacology (2021)
Thomas Soeiro, Elisabeth Frauger, Vincent Pradel, Joëlle Micallef
Doctor shopping for methylphenidate as a proxy for misuse and potential abuse in the 67 million inhabitants in France. Fundamental & clinical pharmacology 35 (4) (2020)
Amélie Daveluy, Joëlle Micallef, Paola Sanchez-Pena, Ghada Miremont-Salamé, Régis Lassalle, Clémentine Lacueille, Angela Grelaud, Virginie Corand, Caroline Victorri-Vigneau, Anne Batisse, Reynald Le Boisselier, Hélène Peyrière, Elisabeth Frauger, Maryse Lapeyre Mestre, Françoise Haramburu
Ten-year trend of opioid and nonopioid analgesic use in the French adult population. British journal of clinical pharmacology 87 (2) (2020)
Gaétan Gentile, Maeva Jego, Michel Spadari, Karolina Griffiths, Emilie Jouanjus, Joëlle Micallef
Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network? Fundamental & clinical pharmacology 32 (6) (2018)
Joëlle Micallef, Julien Dupouey, Elisabeth Jouve, Romain Truillet, Bruno Lacarelle, Jacques Taillard, Agnès Daurat, Colas Authié, Olivier Blin, Olivier Rascol, Pierre Philip, Daniel Mestre
Cannabis smoking impairs driving performance on the simulator and real driving: a randomized, double-blind, placebo-controlled, crossover trial. Fundamental & clinical pharmacology 32 (5) (2018)
Liselotte Pochard, Julie Dupouy, Elisabeth Frauger, Adeline Giocanti, Joëlle Micallef, Maryse Lapeyre Mestre, null null
Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France. Fundamental & clinical pharmacology 32 (2) (2018)
Vanessa Pauly, Elisabeth Frauger, Magalie Lepelley, Michel Mallaret, Quentin Boucherie, Joëlle Micallef
Patterns and profiles of methylphenidate use both in children and adults. British journal of clinical pharmacology 84 (6) (2018)
Joëlle Micallef, Pierre Boutouyrie, Olivier Blin
Pharmacology and drug development in rare diseases: the attractiveness and expertise of the French medical pharmacology. Fundamental & clinical pharmacology 31 (6) (2017)